[e2e] was double blind, now reproduceable results
David P. Reed
dpreed at reed.com
Thu May 20 06:25:04 PDT 2004
At 01:44 AM 5/20/2004, Jon Crowcroft wrote:
>look, if the medical world, with all the finanical and ethical pressures
>on them
>can manage with this problemm (esp. viz genomics, protemics, patent
>fights, patient privacy, and
>pharma indutry), then we are pretty sad if we can't figure it out
The medical world has not figured this out. In discussions with
colleagues, there are lots of points where data is withheld and techniques
are withheld from researchers who would like to reproduce results. They
are struggling with tough issues as well, plus new issues (such as
professors and patent law extremists who are working to build case law that
research use of patented ideas can be blocked - the whole idea of a
"research exception" is being systematically attacked by the patent bar in
areas of medicine).
At least in our arena, we have been building a movement toward open source,
open ideas, etc. (one that I am proud to be a member of). There is little
of that in biomedical science today.
More information about the end2end-interest
mailing list